We use cookies on this site to enable your digital experience. By continuing to use this site, you are agreeing to our cookie policy. close

Anti-Obesity Drug Linked To 5 Deaths In U.K.

Law360 (June 3, 2008, 12:00 AM EDT) -- Acomplia, the Sanofi-Aventis SA anti-obesity drug rejected by the U.S. Food and Drug Administration last year due to fears of psychiatric side effects, has been linked to five deaths, including one suicide, since it went on sale in the United Kingdom in 2006, new data show.

According to a report posted Tuesday on the Web site of the Medicines and Healthcare Products Regulatory Agency, the FDA's U.K. counterpart, 720 people in the U.K. reported adverse drug reactions from use of rimonabant, marketed in the U.K. as...
To view the full article, register now.
Law360 Pro Say Podcast
Check out Law360's new podcast, Pro Say, which offers a weekly recap of both the biggest stories and hidden gems from the world of law.